| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1528 |
| Trial ID | NCT02435186 |
| Disease | Fallopian Tube Cancer | Ovary Epithelial Cancer | Retroperitoneal Cancer |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | rAd-p53 |
| Co-treatment | Cisplatin|Paclitaxel |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | Recombinant Adenoviral p53 Human Gene Combined With Chemotherapy in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
| Year | 2015 |
| Country | China |
| Company sponsor | Shenzhen SiBiono GeneTech Co.,Ltd |
| Other ID(s) | rAd-p53-H20150111 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||||
|
|||||||||